Events Voice of GCC 2025: Highlighting Strategy, Collaboration, and Celebration A powerful celebration of teamwork and achievement that inspires every member to reach new heights. GCC sparks the collective energy fueling Venus Remedies’ journey to becoming a global leader.
Accreditations & Approvals Venus Remedies Secures Renewal of GMP Certification from Ukraine’s SMDC With renewed GMP certification from Ukraine’s SMDC, Venus Remedies showcases its commitment to world-class manufacturing standards. This milestone supports its continued growth in global pharmaceutical markets.
Employee Benefits Venus Remedies Rolls Out a Comprehensive Family Medical Insurance Policy Venus Remedies introduces an extensive Family Medical Insurance Policy to safeguard employee well-being. This initiative underscores the company's continued commitment to health, care, and long-term security.
Awards PPL 2025 Finale: A Day Dedicated to Winners & Passion Venus Remedies wrapped up PPL 2024 by celebrating the passion, performance, and perseverance of all participants. The finale highlighted outstanding contributions, teamwork, and the spirit that defined this year’s event.
Associations Another Big Milestone Achieved: Collaborating with UNGC for a Better Future We've officially joined the United Nations Global Compact! This isn’t just a partnership, it’s commitment to working towards a world where business drives progress with purpose.
Accreditations & Approvals Venus Remedies Secures EU GMP Renewal from Infarmed, Strengthens Hold on European Market Venus Remedies achieves the EU GMP renewal from Infarmed, underscoring its precision-driven manufacturing practices. This achievement boosts its advancement in Europe, paving the way for wider market integration and competitive edge throughout the region.
Accreditations & Approvals Philippines Approves Sugammadex: Venus Remedies Strengthens Global Reach Venus Remedies expands its global footprint as the Philippines grants marketing approval for Sugammadex, a breakthrough anesthetic reversal drug.
News Unlocking a New Milestone: US FDA Grants QIDP Status to VRP-034! We are proud to share a landmark achievement in our journey at Venus Remedies Limited—one that shines a global spotlight on India’s role in tackling one of the world’s most pressing healthcare challenges: antimicrobial resistance (AMR). The U.S. Food and Drug Administration (FDA) has awarded Qualified
